A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects.

about

Tbo-Filgrastim: A Review in Neutropenic Conditions.

P2860

Q38792513-BEA1355B-A31D-41CA-A3A9-40C34A747DAA

P2860

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects.

Item

http://www.wikidata.org/entity/Q35633293

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A thorough QT study to assess ...... arization in healthy subjects.

@ast

A thorough QT study to assess ...... arization in healthy subjects.

@en

type

Item

label

A thorough QT study to assess ...... arization in healthy subjects.

@ast

A thorough QT study to assess ...... arization in healthy subjects.

@en

prefLabel

A thorough QT study to assess ...... arization in healthy subjects.

@ast

A thorough QT study to assess ...... arization in healthy subjects.

@en

P1476

A thorough QT study to assess ...... arization in healthy subjects.

@en

P2093

Andreas Lammerich

http://www.w3.org/2001/XMLSchema#string

Liat Adar

http://www.w3.org/2001/XMLSchema#string

Noa Avisar

http://www.w3.org/2001/XMLSchema#string

Ofer Spiegelstein

http://www.w3.org/2001/XMLSchema#string

Robert B Kleiman

http://www.w3.org/2001/XMLSchema#string

P2860

Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development

In vitro activity of BAY 12-8039, a new fluoroquinolone

Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.

Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics.

Clinical pharmacology considerations in biologics development.

XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy.

P304

2653-2662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S81799

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26028962

http://www.w3.org/2001/XMLSchema#string

P932

4440426

http://www.w3.org/2001/XMLSchema#string

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects.

about

P2860

P2860

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932